ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2014 42nd Annual Meeting | |
| Thomas R. Friberg, MD | The Peripheral Retina and its Implications for Age-Related Macular Degeneration |
| Julia A. Haller, MD | Nothing in Vein: The Evolution of Management of Retinal Vein Occlusions |
| Szilárd Kiss, MD | Latest Observations on Wide-Field Imaging of Retinal Diseases |
| David W. Parke, II, MD | The Law of Unintended Consequences in Health Care Reform |
| Carl D. Regillo, MD | Anti-VEGF Maintenance Therapy for Neovascular AMD |
| Srinivas R. Sadda, MD | Future Optical Coherence Tomography (OCT) Imaging |
| Srinivas R. Sadda, MD | Local Risk Factors for Development of Geographic Atrophy: New Insights into AMD Pathogenesis |
| Ramin Tadayoni, MD, PhD | High Myopia: What We Peel and What We Should Peel |
| Ramin Tadayoni, MD, PhD | Is Fluorescein Angiography Still the Sole Gold Standard for the Diagnosis of Neovascular AMD? |
| 2013 41st Annual Meeting | |
| David M. Brown, MD | Can Widefield FFA-guided PRP Decrease Treatment Burden in Vascular Diseases? |
| David M. Brown, MD | Is There a Correlation Between Changes in OCT and Visual Acuity in the Management of Wet ARMD? |
| Philip J. Ferrone, MD | Advanced Imaging and Intravitreal Therapy in the Pediatric Patient |
| Philip J. Ferrone, MD | Pediatric Retina Surgery — Update and Clinical Pearls |
| Tarek S. Hassan, MD | The Continued Evolution of Vitrectomy: How it Impacts Current Clinical Care |
| Tarek S. Hassan, MD | The Current Management of Refractory Diabetic Macular Edema |
| Daniel F. Martin, MD | Lessons Learned in the Management of Posterior Uveitis |
| Daniel F. Martin, MD | Top 10 Findings from the Comparison of AMD Treatments Trials (CATT) |
| Joan W. Miller, MD | Current and Future Therapies of AMD |
| Joan W. Miller, MD | Neuroprotection for Retinal Disorders |
| Virgilio Morales-Canton, MD | Endophthalmitis from the Retina Surgeon’s Perspective — Complications of Intravitreal Injection Therapy and Pars Plana Vitrectomy |
| Virgilio Morales-Canton, MD | Vitrectomy Management of Complications of Diabetic Retinopathy |
| Timothy G. Murray, MD, MBA | Update on Management for Complex Pediatric Retinoblastoma and Melanoma: Impact of Imaging, Anti-VEGF, and Metabolism on Tumor Control and Functional Outcome |
| David W. Parke, II, MD | What’s the Election’s Healthcare Impact? What Happens Now? |
| John T. Thompson, MD | Advances in the Treatment of Lamellar and Full-Thickness Macular Holes |
| John T. Thompson, MD | Does Vitrectomy Increase the Risk for Development of Glaucoma? |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 | NEXT |
